Genetic variants as predictive markers for ototoxicity and nephrotoxicity in patients (pts) with locally advanced head and neck cancer (LAHNC) treated with cisplatin-containing chemoradiotherapy ...
A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00–10:00) flat infusion of 5-fluorouracil (5-FU) ...
PURPOSE: To compare protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin (MMC) in patients with advanced pancreatic cancer in a multicenter, prospectively randomized study ...
Patients were eligible for inclusion in this single-centre, phase I, open-label, dose-escalation trial if they had histologically confirmed, advanced adenocarcinoma of the colon or rectum, with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Administration of 5-FU bolus did not affect survival for ...
Patients receiving 5-fluorouracil (5-FU) for gastrointestinal cancers have a significantly higher 6- and 12-month risk for myocardial infarction (MI) but the absolute numbers are low, new research ...
SAN FRANCISCO-Two studies presented at the 37th Annual Meeting of the American Society of Clinical Oncology (ASCO) show no advantage to adding fluorouracil (5-FU) to gemcitabine (Gemzar) in patients ...
From the results of recent studies, it is likely that multimodality therapy with chemotherapy and radiation treatment may improve the overall outcome of locally advanced upper gastrointestinal (GI) ...
June 17, 2009 (Orlando, Florida) — There is now an antidote for clinicians to use in the event of an overdose of the commonly used chemotherapy 5-fluorouracil (5-FU), according to a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results